Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study.

BMC Cancer · 2013 · PMC3665449 · PMID 23693095

Europe PMC DOI

hedged sentence

0.4200

closest p · 8.4× alpha

0.4200

boldest claim

The sentences

did not reach statistical significancep=0.42not close (p > 0.1)

We observed a tendency of correlation with therapeutic response and the present status of patients, but it did not reach statistical significance (p=0.42) (Figure 3 b).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.